Navigation Links
World Heart Corp. Completes $7.3 Million Private Placement
Date:1/26/2010

SALT LAKE CITY, Jan. 26 /PRNewswire-FirstCall/ -- World Heart Corporation ("WorldHeart"; Nasdaq: WHRT), a developer of mechanical circulatory systems, announced today that it has completed its previously announced private placement of common stock and warrants to purchase common stock. Gross proceeds from the offering were approximately $7.3 million. Proceeds from the private placement are expected to be used for general corporate and working capital purposes.

WorldHeart issued an aggregate of 1,418,726 newly-issued shares of common stock and warrants to purchase up to 2,837,452 additional shares of common stock. WorldHeart expects to receive net proceeds of approximately $7.1 million after deducting offering expenses.

The financing was led by existing investors, Special Situations Funds, Venrock and New Leaf Venture Partners, and included several new investors. Thomas Weisel Partners LLC acted as Placement Agent on the private placement.

In connection with the financing, WorldHeart has agreed, subject to certain terms and conditions, to file a registration statement under the Securities Act covering the registration of the common stock and the shares underlying the warrants acquired at closing within 60 days after closing.

This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities.

For additional information, please refer to WorldHeart's current report on Form 8-K filed with the Securities and Exchange Commission with respect to this transaction.

About WorldHeart

WorldHeart is a developer of mechanical circulatory support systems headquartere
'/>"/>

SOURCE World Heart Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Aspirin Named 8th World Wonder by Majority of Americans
3. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
(Date:8/20/2014)... Reportlinker.com announces that a new market research report ... Patient Scales Industry http://www.reportlinker.com/p01374301/Global-Patient-Scales-Industry.html ... markets for Patient Scales in US$ Thousand by ... Baby Scales, Chair Scales, and Under Bed Scales. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ...
(Date:8/20/2014)... England , August 20, 2014 ... be Conducted in the US  KalVista Pharmaceuticals ... macular edema (DME), today announces that it has begun ... novel plasma kallikrein inhibitor, KVD001, for the treatment of ... Sun of the Beetham Eye Institute, Joslin Diabetes Center; ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... 2011 Insmed Incorporated (Nasdaq: INSM ), a ... call on Thursday, March 10th, 2011, at 8:30 AM EST, ... year-end 2010.  Insmed intends to issue its quarterly and year-end ... 10th. To participate in the live conference ...
... 23, 2011 Reportlinker.com announces that a new ... Global Fetal Monitors Industry ... report analyzes the worldwide markets for Fetal Monitors ... Antepartum Monitors, and Intrapartum Monitors. The report provides ...
Cached Medicine Technology:Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call 2
(Date:8/21/2014)... AZ (PRWEB) August 21, 2014 Drake ... have donated $10,000 to support ovarian cancer research, according ... Cundiff, who is also the kicker for the Cleveland ... Cancer Event was matched by Colleen’s Dream Foundation and ... MD, an Assistant Professor in the Division of Gynecologic ...
(Date:8/21/2014)... 2014 InSilico Medicine, a ... addressing the challenges of a rapidly aging ... signalome-wide pathway analysis. This new method ... of gene expression data obtained using high-throughput ... the journal Frontiers in Molecular Biosciences, shows ...
(Date:8/21/2014)... Today, Fecbek.com, a leading wedding dresses manufacturer ... wedding dresses. And all these elegant, gorgeous and beautiful ... designers. , A wedding dress or wedding gown is ... ceremony. Color, style and ceremonial importance of the gown ... wedding participants. In order to satisfy every customer, Fecbek.com ...
(Date:8/20/2014)... Most people think of donating food around the ... for a variety of reasons—thus making these months some ... need, Dr. Bryne Willey of AlignLife of Springfield ... wanted to heighten awareness of the need in the ... in July food drive to collect non-perishable foods for ...
(Date:8/20/2014)... Skmen.com, the popular online supplier of men’s and women’s clothes, ... online. Along with this, the company has also launched ... fresh products are offered with great discounts and low shipping ... before August 31. , Skmen.com has more than 200 ... proportion of its clothes are selling well in the current ...
Breaking Medicine News(10 mins):Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2Health News:AlignLife Springfield Office Donates 565 Canned Goods to Springfield Food Pantry 2Health News:Skmen.com: New Designs Of Mini Party Dresses Provided Online 2
... cancer will be the single leading cause of death ... stroke. Already cancer causes more deaths than HIV/AIDS, tuberculosis ... occur in developing countries, with more than a million ... Health Organization projections. , , Scot Remick, M.D., ...
... Speaker Nancy Pelosi spoke on the House floor this morning in ... Drug Administration (FDA) with authority to regulate tobacco products. The ... It passed the Senate yesterday and now goes to President ... remarks. , , "It,s really a ...
... 12 The following is a statement from Georges ... Health Association: , , "With today,s House passage of ... regulate tobacco products, our nation has finally turned the corner. ... to market their deadly products to our children and deceive ...
... HLS ) announced today that its board of ... share on its 6.5% Series A Convertible Perpetual Preferred Stock, ... July 1, 2009. , , About HealthSouth ... rehabilitative healthcare services. Operating in 26 states across the country ...
... association remains unclear, however, researchers say, , FRIDAY, June 12 ... the eye sometimes points outward are more likely to develop ... , About 1 percent of developmentally healthy U.S. children are ... line up and one looks away from the nose at ...
... N.Y., June 12 Misonix, Inc. (Nasdaq: ... device technology, which in Europe is used for the ... conditions, announced today that it has purchased three patents ... ProRhythm, Inc. The patents relate to HIFU transducer ...
Cached Medicine News:Health News:WVU Doctor Works to Reduce Cancer Burden in Africa 2Health News:Pelosi: Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 2Health News:Pelosi: Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 3Health News:Kids With Eye Condition at Risk for Poor Mental Health 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 3
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%....
Cancellous or trabecular bone that is crushed - particle size varies - primarily from distal femur, condyles, proximal tibia, femoral head, distal tibia and humeral head. Demineralized cancellous is ...
Demineralized Freeze-dried Bone Allograft (DFDBA) processed from cortical bone. Demineralized cortical powder is free of all soft tissue....
Dedicated ENT electromagnetic surgical navigation system. Value priced for comunity hospitals and surgical centers....
Medicine Products: